Sysmex Corporation Logo

Sysmex Corporation

6869.T

(2.2)
Stock Price

3.060,00 JPY

10.02% ROA

12.21% ROE

34.55x PER

Market Cap.

1.798.173.307.840,00 JPY

12.97% DER

1.01% Yield

10.89% NPM

Sysmex Corporation Stock Analysis

Sysmex Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Sysmex Corporation Fundamental Stock Analysis
# Analysis Rating
1 ROA

This stock has a great ability to make a lot of money from the things it owns, which makes it a really good investment for smart investors.

2 DER

The stock has a low debt to equity ratio (7%), which means it has a small amount of debt compared to the ownership it holds

3 Assets Growth

With continuous growth in revenue over the last five years, this company has proven to be a lucrative investment option, showcasing its strong financial performance.

4 ROE

ROE in an average range (12.34%) suggests satisfactory profitability and decent utilization of shareholders' equity.

5 Dividend

Investors can rely on the company's consistent dividend payments over the past three years, offering a steady stream of returns.

6 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is undervalued (70.599), making it an appealing investment prospect with its intrinsic value surpassing the current market price.

7 PBV

The stock's elevated P/BV ratio (4.57x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

8 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Net Profit Growth

Throughout the last five years, this company's net profit has remained unchanged, indicating a lack of growth and making it a less favorable investment option.

10 Graham Number

The Graham number analysis indicates that this company's stock price is likely overpriced, raising concerns about its investment potential.

11 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

Sysmex Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Sysmex Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Sysmex Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Sysmex Corporation Revenue
Year Revenue Growth
2004 76.934.000.000
2005 87.887.000.000 12.46%
2006 101.041.000.000 13.02%
2007 110.724.000.000 8.75%
2008 111.842.000.000 1%
2009 116.174.000.000 3.73%
2010 124.694.000.000 6.83%
2011 134.743.000.000 7.46%
2012 145.577.000.000 7.44%
2013 184.538.000.000 21.11%
2014 221.376.000.000 16.64%
2015 253.157.000.000 12.55%
2016 249.899.000.000 -1.3%
2017 281.935.000.000 11.36%
2018 293.506.000.000 3.94%
2019 301.980.000.000 2.81%
2020 305.073.000.000 1.01%
2021 363.780.000.000 16.14%
2022 410.502.000.000 11.38%
2023 469.388.000.000 12.55%
2023 461.510.000.000 -1.71%
2024 447.784.000.000 -3.07%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Sysmex Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 12.119.000.000 100%
2013 13.260.000.000 8.6%
2014 14.692.000.000 9.75%
2015 15.409.000.000 4.65%
2016 15.554.000.000 0.93%
2017 16.754.000.000 7.16%
2018 19.578.000.000 14.42%
2019 21.761.000.000 10.03%
2020 22.517.000.000 3.36%
2021 26.784.000.000 15.93%
2022 31.060.000.000 13.77%
2023 31.520.000.000 1.46%
2023 31.402.000.000 -0.38%
2024 29.424.000.000 -6.72%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Sysmex Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 75.401.000.000 100%
2017 82.544.000.000 8.65%
2018 81.230.000.000 -1.62%
2019 83.545.000.000 2.77%
2020 80.839.000.000 -3.35%
2021 94.235.000.000 14.22%
2022 112.371.000.000 16.14%
2023 129.772.000.000 13.41%
2023 133.798.000.000 3.01%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Sysmex Corporation EBITDA
Year EBITDA Growth
2004 13.208.000.000
2005 15.603.000.000 15.35%
2006 17.592.000.000 11.31%
2007 19.015.000.000 7.48%
2008 21.102.000.000 9.89%
2009 23.619.000.000 10.66%
2010 25.625.000.000 7.83%
2011 27.247.000.000 5.95%
2012 31.846.000.000 14.44%
2013 45.220.000.000 29.58%
2014 58.951.000.000 23.29%
2015 68.575.000.000 14.03%
2016 61.699.000.000 -11.14%
2017 72.818.000.000 15.27%
2018 74.187.000.000 1.85%
2019 74.419.000.000 0.31%
2020 74.474.000.000 0.07%
2021 92.686.000.000 19.65%
2022 104.454.000.000 11.27%
2023 117.616.000.000 11.19%
2023 113.185.000.000 -3.91%
2024 106.124.000.000 -6.65%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Sysmex Corporation Gross Profit
Year Gross Profit Growth
2004 44.131.000.000
2005 51.148.000.000 13.72%
2006 57.544.000.000 11.11%
2007 65.328.000.000 11.92%
2008 71.004.000.000 7.99%
2009 73.694.000.000 3.65%
2010 78.305.000.000 5.89%
2011 83.091.000.000 5.76%
2012 88.995.000.000 6.63%
2013 115.724.000.000 23.1%
2014 126.018.000.000 8.17%
2015 151.094.000.000 16.6%
2016 141.777.000.000 -6.57%
2017 158.949.000.000 10.8%
2018 161.607.000.000 1.64%
2019 159.807.000.000 -1.13%
2020 154.303.000.000 -3.57%
2021 190.585.000.000 19.04%
2022 216.083.000.000 11.8%
2023 242.424.000.000 10.87%
2023 242.497.000.000 0.03%
2024 240.160.000.000 -0.97%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Sysmex Corporation Net Profit
Year Net Profit Growth
2004 5.731.000.000
2005 7.422.000.000 22.78%
2006 9.008.000.000 17.61%
2007 9.131.000.000 1.35%
2008 8.013.000.000 -13.95%
2009 9.764.000.000 17.93%
2010 11.411.000.000 14.43%
2011 12.007.000.000 4.96%
2012 14.165.000.000 15.23%
2013 20.573.000.000 31.15%
2014 26.638.000.000 22.77%
2015 36.233.000.000 26.48%
2016 40.635.000.000 10.83%
2017 39.221.000.000 -3.61%
2018 41.224.000.000 4.86%
2019 34.882.000.000 -18.18%
2020 31.904.000.000 -9.33%
2021 44.092.000.000 27.64%
2022 45.784.000.000 3.7%
2023 54.260.000.000 15.62%
2023 49.639.000.000 -9.31%
2024 44.124.000.000 -12.5%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Sysmex Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 56
2005 36 -55.56%
2006 45 18.18%
2007 45 0%
2008 39 -12.82%
2009 95 58.95%
2010 56 -72.73%
2011 29 -89.66%
2012 23 -31.82%
2013 33 33.33%
2014 43 21.43%
2015 58 27.59%
2016 65 10.77%
2017 63 -4.84%
2018 66 4.62%
2019 56 -18.18%
2020 53 -5.77%
2021 70 25.71%
2022 73 2.78%
2023 259 72.2%
2023 79 -227.85%
2024 71 -12.86%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Sysmex Corporation Free Cashflow
Year Free Cashflow Growth
2004 2.545.000.000
2005 1.059.000.000 -140.32%
2006 3.970.000.000 73.32%
2007 909.000.000 -336.74%
2008 2.219.000.000 59.04%
2009 14.805.000.000 85.01%
2010 10.345.000.000 -43.11%
2011 8.619.000.000 -20.03%
2012 13.995.000.000 38.41%
2013 19.469.000.000 28.12%
2014 22.152.000.000 12.11%
2015 19.715.000.000 -12.36%
2016 13.726.000.000 -43.63%
2017 26.545.000.000 48.29%
2018 15.765.000.000 -68.38%
2019 26.710.000.000 40.98%
2020 33.020.000.000 19.11%
2021 26.705.000.000 -23.65%
2022 26.330.000.000 -1.42%
2023 7.191.000.000 -266.15%
2023 12.873.000.000 44.14%
2024 13.223.000.000 2.65%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Sysmex Corporation Operating Cashflow
Year Operating Cashflow Growth
2004 6.691.000.000
2005 8.275.000.000 19.14%
2006 10.085.000.000 17.95%
2007 11.634.000.000 13.31%
2008 13.193.000.000 11.82%
2009 21.229.000.000 37.85%
2010 18.135.000.000 -17.06%
2011 17.058.000.000 -6.31%
2012 25.806.000.000 33.9%
2013 36.563.000.000 29.42%
2014 38.640.000.000 5.38%
2015 39.567.000.000 2.34%
2016 32.832.000.000 -20.51%
2017 52.240.000.000 37.15%
2018 44.743.000.000 -16.76%
2019 53.182.000.000 15.87%
2020 58.813.000.000 9.57%
2021 58.739.000.000 -0.13%
2022 68.835.000.000 14.67%
2023 19.328.000.000 -256.14%
2023 63.905.000.000 69.76%
2024 17.966.000.000 -255.7%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Sysmex Corporation Capital Expenditure
Year Capital Expenditure Growth
2004 4.146.000.000
2005 7.216.000.000 42.54%
2006 6.115.000.000 -18%
2007 10.725.000.000 42.98%
2008 10.974.000.000 2.27%
2009 6.424.000.000 -70.83%
2010 7.790.000.000 17.54%
2011 8.439.000.000 7.69%
2012 11.811.000.000 28.55%
2013 17.094.000.000 30.91%
2014 16.488.000.000 -3.68%
2015 19.852.000.000 16.95%
2016 19.106.000.000 -3.9%
2017 25.695.000.000 25.64%
2018 28.978.000.000 11.33%
2019 26.472.000.000 -9.47%
2020 25.793.000.000 -2.63%
2021 32.034.000.000 19.48%
2022 42.505.000.000 24.63%
2023 12.137.000.000 -250.21%
2023 51.032.000.000 76.22%
2024 4.743.000.000 -975.94%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Sysmex Corporation Equity
Year Equity Growth
2004 56.149.000.000
2005 62.646.000.000 10.37%
2006 72.396.000.000 13.47%
2007 79.117.000.000 8.5%
2008 79.850.000.000 0.92%
2009 87.136.000.000 8.36%
2010 94.232.000.000 7.53%
2011 102.502.000.000 8.07%
2012 119.152.000.000 13.97%
2013 146.248.000.000 18.53%
2014 169.549.000.000 13.74%
2015 188.092.000.000 9.86%
2016 210.251.000.000 10.54%
2017 241.442.000.000 12.92%
2018 265.181.000.000 8.95%
2019 278.346.000.000 4.73%
2020 308.669.000.000 9.82%
2021 349.053.000.000 11.57%
2022 388.355.000.000 10.12%
2023 432.897.000.000 10.29%
2023 420.122.000.000 -3.04%
2024 448.783.000.000 6.39%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Sysmex Corporation Assets
Year Assets Growth
2004 77.660.000.000
2005 87.446.000.000 11.19%
2006 101.225.000.000 13.61%
2007 109.027.000.000 7.16%
2008 118.521.000.000 8.01%
2009 120.702.000.000 1.81%
2010 130.059.000.000 7.19%
2011 142.285.000.000 8.59%
2012 173.009.000.000 17.76%
2013 210.756.000.000 17.91%
2014 247.982.000.000 15.01%
2015 267.635.000.000 7.34%
2016 279.817.000.000 4.35%
2017 321.979.000.000 13.09%
2018 346.775.000.000 7.15%
2019 389.291.000.000 10.92%
2020 427.475.000.000 8.93%
2021 483.707.000.000 11.63%
2022 531.074.000.000 8.92%
2023 618.920.000.000 14.19%
2023 557.834.000.000 -10.95%
2024 626.249.000.000 10.92%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Sysmex Corporation Liabilities
Year Liabilities Growth
2004 21.511.000.000
2005 24.800.000.000 13.26%
2006 28.829.000.000 13.98%
2007 29.910.000.000 3.61%
2008 38.671.000.000 22.66%
2009 33.566.000.000 -15.21%
2010 35.827.000.000 6.31%
2011 39.783.000.000 9.94%
2012 53.857.000.000 26.13%
2013 64.508.000.000 16.51%
2014 78.433.000.000 17.75%
2015 79.543.000.000 1.4%
2016 69.565.000.000 -14.34%
2017 80.536.000.000 13.62%
2018 81.593.000.000 1.3%
2019 110.944.000.000 26.46%
2020 118.806.000.000 6.62%
2021 134.654.000.000 11.77%
2022 142.718.000.000 5.65%
2023 186.020.000.000 23.28%
2023 137.712.000.000 -35.08%
2024 177.466.000.000 22.4%

Sysmex Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
766.72
Net Income per Share
83.47
Price to Earning Ratio
34.55x
Price To Sales Ratio
3.76x
POCF Ratio
25.5
PFCF Ratio
71.29
Price to Book Ratio
4.01
EV to Sales
3.7
EV Over EBITDA
15.02
EV to Operating CashFlow
25.1
EV to FreeCashFlow
70.18
Earnings Yield
0.03
FreeCashFlow Yield
0.01
Market Cap
1.798,17 Bil.
Enterprise Value
1.770,20 Bil.
Graham Number
1161.54
Graham NetNet
87.34

Income Statement Metrics

Net Income per Share
83.47
Income Quality
1.1
ROE
0.12
Return On Assets
0.08
Return On Capital Employed
0.16
Net Income per EBT
0.66
EBT Per Ebit
0.96
Ebit per Revenue
0.17
Effective Tax Rate
0.33

Margins

Sales, General, & Administrative to Revenue
0.22
Research & Developement to Revenue
0.07
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.53
Operating Profit Margin
0.17
Pretax Profit Margin
0.16
Net Profit Margin
0.11

Dividends

Dividend Yield
0.01
Dividend Yield %
1.01
Payout Ratio
0.34
Dividend Per Share
29

Operating Metrics

Operating Cashflow per Share
113.1
Free CashFlow per Share
40.45
Capex to Operating CashFlow
0.64
Capex to Revenue
0.09
Capex to Depreciation
1.21
Return on Invested Capital
0.11
Return on Tangible Assets
0.1
Days Sales Outstanding
111.92
Days Payables Outstanding
44.62
Days of Inventory on Hand
142.68
Receivables Turnover
3.26
Payables Turnover
8.18
Inventory Turnover
2.56
Capex per Share
72.65

Balance Sheet

Cash per Share
124,78
Book Value per Share
719,70
Tangible Book Value per Share
548.11
Shareholders Equity per Share
718.41
Interest Debt per Share
97.33
Debt to Equity
0.13
Debt to Assets
0.09
Net Debt to EBITDA
-0.24
Current Ratio
3.23
Tangible Asset Value
341,79 Bil.
Net Current Asset Value
164,85 Bil.
Invested Capital
462101000000
Working Capital
236,47 Bil.
Intangibles to Total Assets
0.17
Average Receivables
160,57 Bil.
Average Payables
24,87 Bil.
Average Inventory
83729000000
Debt to Market Cap
0.03

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Sysmex Corporation Dividends
Year Dividends Growth
2001 69
2002 66 -4.55%
2003 47 -40.43%
2004 99 52.53%
2005 195 49.23%
2006 54 -261.11%
2007 120 55%
2008 92 -30.43%
2009 153 39.87%
2010 177 13.56%
2011 141 -25.53%
2012 108 -30.56%
2013 75 -44%
2014 147 48.98%
2015 78 -88.46%
2016 168 53.57%
2017 180 6.67%
2018 120 -50%
2019 216 44.44%
2020 216 0%
2021 219 1.37%
2022 237 7.59%
2023 132 -79.55%
2024 57 -131.58%
2025 0 0%

Sysmex Corporation Profile

About Sysmex Corporation

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. The company offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. It also provides urine formed sediment analysis systems; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, the company offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; cancer genome profiling systems; and cytogenic testing and lab assay services. It is also involved in the development and sale of software for diagnostic information systems; provision of facility management, office, and welfare services; development, manufacture, and sale of nucleic acid analogs; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. Sysmex Corporation has a strategic alliance with QIAGEN N.V. for the development and commercialization of cancer companion diagnostics using Plasma-Safe-SeqS technology. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.

CEO
Mr. Kaoru Asano
Employee
10.042
Address
1-5-1, Wakinohama-Kaigandori
Kobe, 651-0073

Sysmex Corporation Executives & BODs

Sysmex Corporation Executives & BODs
# Name Age
1 Mr. Kenji Tachibana
Senior Managing Executive Officer & Director
70
2 Mr. Kaoru Asano
President & Representative Director
70
3 Mr. Chris Cappella
Chief Financial Officer
70
4 Mr. Frank Buescher
Senior Executive Officer
70
5 Mr. Iwane Matsui
Senior Managing Executive Officer & Director
70
6 Mr. Mitsuhisa Kanagawa
Senior Exec Officer of IVD Business Unit & EVice President of Business Strategy Dev
70
7 Mr. Takashi Ono
Director & Senior Executive Officer
70
8 Mr. Tomokazu Yoshida
Managing Executive Officer, Chief Technology Officer & Director
70
9 Mr. Kensuke Iizuka
Senior Executive Officer & Executive Vice President of Corporate Business Planning Div.
70
10 Mr. Zuo Hui Peng
Executive Officer
70

Sysmex Corporation Competitors

Terumo Corporation Logo
Terumo Corporation

4543.T

(3.0)
Olympus Corporation Logo
Olympus Corporation

7733.T

(2.5)
HOYA Corporation Logo
HOYA Corporation

7741.T

(2.8)
Eisai Co., Ltd. Logo
Eisai Co., Ltd.

4523.T

(2.8)
M3, Inc. Logo
M3, Inc.

2413.T

(3.2)